Results of a 2‐arm, phase 2 clinical trial using post‐transplantation cyclophosphamide for the prevention of graft‐versus‐host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation
暂无分享,去创建一个
K. Rezvani | D. Marin | E. Shpall | Y. Nieto | U. Popat | Q. Bashir | M. Qazilbash | A. Alousi | Sa A. Wang | Dean Anthony Lee | R. Champlin | D. Petropoulos | C. Tomuleasa | C. Hosing | P. Kebriaei | I. Khouri | B. Oran | S. Ciurea | N. Shah | S. Gaballa | Julianne J Chen | J. Brammer | G. Alatrash | K. Cao | M. Korbling | Lindsey R. Lombardi | Aimee E. Hammerstrom | Isabell Ge | Saira S. Ahmed | G. Rondon | Piyanuch Kongtim | Riad El Fakih